2001

Mar 27, 2001
Guidant Announces Nomination of Former HCFA Administrator to Its Board of Directors

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that its Board of Directors has nominated Nancy-Ann DeParle to...

Mar 26, 2001
Guidant's Intravascular Radiotherapy System Enjoys Continued Success in Europe

Company Satisfies European Post-Marketing Requirements for its GALILEO System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Mar 20, 2001
Clinical Study Demonstrates Decreased Risk of Neurological Complications for Patients Undergoing Beating Heart Surgery

Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study1 show that among patients experiencing neurological complications after coronary artery bypass surgery, those who...

Mar 16, 2001
Guidant Attains U.S. Coronary Angioplasty Market Leadership, Reinforcing its Position as the Global Leader in Interventional Cardiology

Company Announces Worldwide Approval of POWERSAIL and HIGHSAIL Coronary Dilatation Catheters Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in...

Mar 16, 2001
Guidant Voluntarily Halts Production and Sales of Endovascular Graft

Patients With Implanted Devices Not Affected by this Action Indianapolis, IN and Menlo Park, CA - Guidant Corporation (NYSE and PCX: GDT) today announced it has voluntarily halted production and...

Mar 15, 2001
Guidant to Host General Briefing at the American College of Cardiology Meeting

All Are Invited to Access the Guidant Briefing By Live Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a general...

Feb 28, 2001
Guidant Announces FDA Filing for Heart Failure Treatment

Company First to File for Approval of Cardiac Resynchronization Therapy Defibrillator for Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX:GDT), a...

Feb 21, 2001
Guidant Expands its Product Offerings for the Treatment of Coronary Artery Disease

Company Receives CE Mark Approval on Latest Coronary Stent System and Filed for U.S. Approval Earlier This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...

Feb 16, 2001
Guidant Launches New Coronary Stent System in Japan

Company Also Increases Direct Sales Organization to Support New Product Introductions Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Feb 6, 2001
Guidant's Drug Eluting Stent System Shown to Reduce Restenosis in Pre-Clinical Models

Human Evaluation Expected to Begin in the Second Quarter of This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Feb 5, 2001
Guidant to Participate in Merrill Lynch Global Healthcare Conference

Investors Are Invited to Access the Guidant Presentation by Live Webcast INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today announced that it...

Jan 30, 2001
Guidant Reports Fourth Quarter Sales Increase of 13 Percent to $649 Million; Record Fourth Quarter Earnings, as Adjusted, of $0.41 per Share

Full Year Net Income Grew 20 Percent, as Adjusted Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today reported fourth quarter sales were $648.8...

Jan 29, 2001
Guidant Introduces New Beating Heart Coronary Artery Bypass Platform

Indianapolis, Ind. and Cupertino, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular disease, announced today the introduction of a new product...

Jan 29, 2001
Guidant Announces Live Webcast of its Fourth Quarter and Year-End 2000 Earnings Conference Call

INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its fourth quarter and year-end 2000 earnings...

Jan 29, 2001
Guidant to Focus Heart Failure Efforts on Cardiac Resynchronization Therapy

Opts not to Acquire Impulse Dynamics Technology; Will Recognize Charge in Fourth Quarter of 2000 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jan 29, 2001
Guidant Organizes to Enhance Focus on New Therapies

Company Forms Endovascular Solutions and Guidant Cardiac Surgery Groups Indianapolis, Ind. and Santa Clara and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jan 29, 2001
Guidant Announces Comprehensive Web Site With Patient- and Physician-Friendly Focus

New Site Responds to Consumer Interest in Healthcare Information Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, announced today its new...

Jan 26, 2001
Guidant to Host Investor Briefing at American College of Cardiology Meeting

Jan 26, 2001
New Study Shows Guidant's Heart Failure Technology Delivers a Marked Improvement for a Solid Majority of Patients

Company's CONTAK Registry Reflects Experience of 1,000 European Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in heart...

Jan 4, 2001
Guidant Pre-Announces Fourth Quarter Revenues and Impact on Earnings Per Share

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, announced fourth quarter revenues of approximately $649 million, reflecting sales...

Jul 19, 2001
First Patients in Japan Treated with Guidant's Carotid Stent

Clinical Study to Evaluate Novel Stroke Prevention Alternative for Japanese Patients Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Apr 19, 2001
Guidant Expands Company's Non-Coronary Stent Offering

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today it has received...

Show per page

Top